Reuters Health Report

Click to View in Browser 02/18/2014 Germany's stance on pricing threatens drug firm profits FRANKFURT/BERLIN (Reuters) - Germany's plan to publish price discounts agreed with drugmakers poses a risk to profits in the industry, which fears the information could be used to drive down prices elsewhere. U.S. regulator on India visit calls for greater drug safety collaboration MUMBAI (Reuters) - The head of the U.S. Food and Drug Administration (FDA) called for more collaboration among regulators to improve drug quality and safety as she wrapped up a visit to India after recent import bans on drugs from a handful of plants in the country. Dynavax withdraws EU marketing application for Hep B vaccine (Reuters) - Dynavax Technologies Corp said it had withdrawn a European marketing application for its experimental hepatitis B vaccine due to safety concerns raised by the European Medicines Agency. Prana's brain disorder drug succeeds in study, shares soar (Reuters) - Prana Biotechnology Ltd said its experimental drug to treat a hereditary degenerative brain disorder met the main goals of safety and tolerability in a mid-stage study, sending its shares up about 42 percent in premarket trade. Months after rehab, knee and hip patients keep improving NEW YORK (Reuters Health) - People who have had a knee or hip replacement reap the benefits of intense rehab months after they've returned home, according to a new analysis. Effects of bullying may add up in kids: study NEW YORK (Reuters Health) - The negative physical and mental effects tied to bullying among children and teens may accumulate throughout the years, according to a new study. Sanofi wins EU approval for NexGard chew against dog fleas PARIS (Reuters) - Sanofi said on Tuesday that its Merial animal health division won European Commission approval for its NexGard oral treatment for flea and tick infestations in dogs. Big tobacco returns to British TV with BAT e-cig advert LONDON (Reuters) - British American Tobacco will become the biggest tobacco company to show a television advert for e-cigarettes in Britain on Monday but will leave out any reference to 'smokers' to comply with laws which ban the promotion of tobacco products. Kids who use snus before age 16 more likely to become smokers NEW YORK (Reuters Health) - Norwegians who started using snus before age 16 were more likely to become cigarette smokers than those who started using snus later in life, according to a new study. First biomarker could help boys at risk of major depression LONDON (Reuters) - British brain scientists have identified the first biomarker, or biological signpost, for clinical depression and say it could help find boys in particular who are at risk of developing the debilitating mental illness. Related Video For competing jackdaws, the eyes have it Nigeria harnesses the power of waste The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend